Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion type Assertion NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_head.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion wasGeneratedBy ECO_0000203 NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_provenance.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion wasDerivedFrom befree-2016 NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_provenance.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion SIO_000772 23276366 NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_provenance.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion evidence source_evidence_literature NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_provenance.
- NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_assertion description "[The RAF inhibitors vemurafenib and dabrafenib are emerging as the standard of care for Val600 BRAF-mutant metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1039520.RAJXGf31rddW2uEEvkUVinP7acBFuo8qFvIVJnkgT-Wx8130_provenance.